205 related articles for article (PubMed ID: 25352572)
1. Synchrotron-based imaging of chromium and γ-H2AX immunostaining in the duodenum following repeated exposure to Cr(VI) in drinking water.
Thompson CM; Seiter J; Chappell MA; Tappero RV; Proctor DM; Suh M; Wolf JC; Haws LC; Vitale R; Mittal L; Kirman CR; Hays SM; Harris MA
Toxicol Sci; 2015 Jan; 143(1):16-25. PubMed ID: 25352572
[TBL] [Abstract][Full Text] [Related]
2. Duodenal crypt health following exposure to Cr(VI): Micronucleus scoring, γ-H2AX immunostaining, and synchrotron X-ray fluorescence microscopy.
Thompson CM; Wolf JC; Elbekai RH; Paranjpe MG; Seiter JM; Chappell MA; Tappero RV; Suh M; Proctor DM; Bichteler A; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2015 Aug; 789-790():61-6. PubMed ID: 26232259
[TBL] [Abstract][Full Text] [Related]
3. Inferred inactivation of the Cftr gene in the duodena of mice exposed to hexavalent chromium (Cr(VI)) in drinking water supports its tumor-suppressor status and implies its potential role in Cr(VI)-induced carcinogenesis of the small intestines.
Mezencev R; Auerbach SS
Toxicol Appl Pharmacol; 2021 Dec; 433():115773. PubMed ID: 34688701
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the mutagenic potential of hexavalent chromium in the duodenum of big blue® rats.
Thompson CM; Young RR; Dinesdurage H; Suh M; Harris MA; Rohr AC; Proctor DM
Toxicol Appl Pharmacol; 2017 Sep; 330():48-52. PubMed ID: 28687238
[TBL] [Abstract][Full Text] [Related]
5. Assessment of K-Ras mutant frequency and micronucleus incidence in the mouse duodenum following 90-days of exposure to Cr(VI) in drinking water.
O'Brien TJ; Ding H; Suh M; Thompson CM; Parsons BL; Harris MA; Winkelman WA; Wolf JC; Hixon JG; Schwartz AM; Myers MB; Haws LC; Proctor DM
Mutat Res; 2013 Jun; 754(1-2):15-21. PubMed ID: 23583686
[TBL] [Abstract][Full Text] [Related]
6. Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues.
Thompson CM; Gregory Hixon J; Proctor DM; Haws LC; Suh M; Urban JD; Harris MA
Regul Toxicol Pharmacol; 2012 Oct; 64(1):68-76. PubMed ID: 22705708
[TBL] [Abstract][Full Text] [Related]
7. NTP toxicity studies of sodium dichromate dihydrate (CAS No. 7789-12-0) administered in drinking water to male and female F344/N rats and B6C3F1 mice and male BALB/c and am3-C57BL/6 mice.
Bucher JR
Toxic Rep Ser; 2007 Jan; (72):1-G4. PubMed ID: 17342194
[TBL] [Abstract][Full Text] [Related]
8. Toxicology and carcinogenesis studies of sodium dichromate dihydrate (Cas No. 7789-12-0) in F344/N rats and B6C3F1 mice (drinking water studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2008 Jul; (546):1-192. PubMed ID: 18716633
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Toxicity and Recovery in the Duodenum of B6C3F1 Mice Following Treatment with Intestinal Carcinogens Captan, Folpet, and Hexavalent Chromium.
Thompson CM; Wolf JC; McCoy A; Suh M; Proctor DM; Kirman CR; Haws LC; Harris MA
Toxicol Pathol; 2017 Dec; 45(8):1091-1101. PubMed ID: 29161989
[TBL] [Abstract][Full Text] [Related]
10. Reevaluation and Classification of Duodenal Lesions in B6C3F1 Mice and F344 Rats from 4 Studies of Hexavalent Chromium in Drinking Water.
Cullen JM; Ward JM; Thompson CM
Toxicol Pathol; 2016 Feb; 44(2):279-89. PubMed ID: 26538584
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the mode of action underlying the tumorigenic response induced in B6C3F1 mice exposed orally to hexavalent chromium.
Thompson CM; Proctor DM; Haws LC; Hébert CD; Grimes SD; Shertzer HG; Kopec AK; Hixon JG; Zacharewski TR; Harris MA
Toxicol Sci; 2011 Sep; 123(1):58-70. PubMed ID: 21712504
[TBL] [Abstract][Full Text] [Related]
12. Crypt and Villus Transcriptomic Responses in Mouse Small Intestine Following Oral Exposure to Hexavalent Chromium.
Chappell GA; Wolf JC; Thompson CM
Toxicol Sci; 2022 Feb; 186(1):43-57. PubMed ID: 34935971
[TBL] [Abstract][Full Text] [Related]
13. Assessment of the mode of action underlying development of rodent small intestinal tumors following oral exposure to hexavalent chromium and relevance to humans.
Thompson CM; Proctor DM; Suh M; Haws LC; Kirman CR; Harris MA
Crit Rev Toxicol; 2013 Mar; 43(3):244-74. PubMed ID: 23445218
[TBL] [Abstract][Full Text] [Related]
14. A chronic oral reference dose for hexavalent chromium-induced intestinal cancer.
Thompson CM; Kirman CR; Proctor DM; Haws LC; Suh M; Hays SM; Hixon JG; Harris MA
J Appl Toxicol; 2014 May; 34(5):525-36. PubMed ID: 23943231
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of hexavalent chromium in the alimentary canal of F344 rats and B6C3F1 mice following exposure in drinking water: implications for carcinogenic modes of action.
Thompson CM; Proctor DM; Suh M; Haws LC; Hébert CD; Mann JF; Shertzer HG; Hixon JG; Harris MA
Toxicol Sci; 2012 Jan; 125(1):79-90. PubMed ID: 22011396
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide gene expression effects in B6C3F1 mouse intestinal epithelia following 7 and 90days of exposure to hexavalent chromium in drinking water.
Kopec AK; Kim S; Forgacs AL; Zacharewski TR; Proctor DM; Harris MA; Haws LC; Thompson CM
Toxicol Appl Pharmacol; 2012 Feb; 259(1):13-26. PubMed ID: 22155349
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vivo genotoxic and carcinogenic potency to augment mode of action analysis: Case study with hexavalent chromium.
Thompson CM; Bichteler A; Rager JE; Suh M; Proctor DM; Haws LC; Harris MA
Mutat Res Genet Toxicol Environ Mutagen; 2016 Apr; 800-801():28-34. PubMed ID: 27085472
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the mode of action for hexavalent chromium-induced lung cancer following inhalation exposures.
Proctor DM; Suh M; Campleman SL; Thompson CM
Toxicology; 2014 Nov; 325():160-79. PubMed ID: 25174529
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the mutagenic potential of Cr(VI) in the oral mucosa of Big Blue® transgenic F344 rats.
Thompson CM; Young RR; Suh M; Dinesdurage HR; Elbekai RH; Harris MA; Rohr AC; Proctor DM
Environ Mol Mutagen; 2015 Aug; 56(7):621-8. PubMed ID: 26010270
[TBL] [Abstract][Full Text] [Related]
20. Exposure to hexavalent chromium resulted in significantly higher tissue chromium burden compared with trivalent chromium following similar oral doses to male F344/N rats and female B6C3F1 mice.
Collins BJ; Stout MD; Levine KE; Kissling GE; Melnick RL; Fennell TR; Walden R; Abdo K; Pritchard JB; Fernando RA; Burka LT; Hooth MJ
Toxicol Sci; 2010 Dec; 118(2):368-79. PubMed ID: 20843897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
